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ABSTRACT 20 
Ischemic preconditioning (IPC) may enhance exercise performance. Cardioprotective effects of IPC 21 
are known to re-occur 24-h after the stimulus. Whether the delayed effect of IPC has similar effects as 22 
IPC on exercise performance is unknown.  23 
Objectives: Examine whether IPC applied 24-hours (24-IPC) before exercise is equally effective as 24 
IPC in improving exercise performance.  25 
Design: Randomized, cross-over study 26 
Methods: 12 healthy participants were randomly exposed to SHAM-session, IPC or 24-IPC before a 27 
self-paced 5 kilometer running trial on a treadmill. Subjects were blinded for time, speed and heart 28 
rate. Furthermore, heart rate, BORG, and the local tissue saturation index were measured during 29 
exercise, while lactate levels were determined  after running. Using a regression model, we explored 30 
whether these parameters predicted the change in running time after IPC and 24-IPC.  31 
Results: We found no differences in finish time after IPC (SHAM: 1400 ± 105 seconds, IPC: 1381 ± 32 
112 seconds, 24-IPC: 1385 ± 113 seconds; P=0.30). However, we observed a significant positive 33 
relation between the change in finish time after IPC and 24-IPC (P=0.016; r=0.677). Using stepwise 34 
linear regression, a lower post-exercise blood lactate level after IPC or 24-IPC was significantly 35 
related to an improvement in finish time (R2=0.47, β=-0.687, P=0.007).   36 
Conclusions: Although no significant effect of IPC or 24-IPC on exercise performance was found, 37 
individual finish time after IPC and 24-IPC were strongly correlated. Therefore, our data suggest that, 38 
at the individual level, the effects of 24-IPC are closely related to the effects of IPC.  39 
KEYWORDS: exercise performance; time trial; athletic performance; preconditioning; ischaemic 40 
preconditioning;   41 
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INTRODUCTION  42 
Ischemic preconditioning (IPC) was originally described as an effective strategy to protect cardiac 43 
cells against a prolonged period of ischemia. In 1986, it was demonstrated that repeated bouts of local 44 
ischemia caused delayed lethal cardiac muscle damage after a prolonged period of ischemia 1. Most 45 
studies have focused on the potential cardioprotective abilities, leading to large, multi-centre trials that 46 
established the potency of IPC to attenuate cardiac damage and improve clinical prognosis 2-4. 47 
 48 
De Groot et al. were the first to explore the ability of IPC to enhance physical performance 5. They 49 
found significant improvement in exercise performance when a maximal cycle test was preceded by 50 
IPC. Similar findings of performance enhancement were reported by others, 6-11 but not all 11-13. Those 51 
studies were mainly designed to assess the direct effect of IPC on exercise performance, while the 52 
working mechanism of IPC on skeletal muscle oxygenation status is less explored.  The limited 53 
number of studies that explored the working mechanism of IPC suggest that IPC may induce systemic 54 
changes in blood flow through a change in sympathetic activity, whereas local changes in the muscle 55 
(e.g. increase oxygen uptake or change in mitochondrial activity) are also likely to contribute to an 56 
increase in muscle oxygenation {Horiuchi, 2015 #32;Kjeld, 2014 #15;Saito, 2004 #14}.  57 
 58 
All previous studies exploring the impact of IPC to exercise performance timed IPC in close proximity 59 
to the exercise event. This poses, however, practical limitations as IPC cannot always be applied in 60 
close proximity to the start of an athletic event. Interestingly, in 1993, two independent groups 61 
reported that the protective effect of IPC (which disappears within hours) reappears after 62 
approximately 24 hours and can last up to 72 hours 14, 15, commonly referred to as the second window 63 
of protection (SWOP). Similar to the traditional IPC studies, the SWOP is associated with a significant 64 
reduction in myocardial infarct size 15. These observations raise the question whether enhanced 65 
performance is also present when IPC is applied 24-72 h prior to the exercise event to match the event 66 
with SWOP. Practically, such timing would be preferred over the application of IPC immediately 67 
before an athletic event.  68 
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 69 
The primary aim of this study, therefore, was to assess our hypothesis whether IPC applied 24-hours 70 
before the running trial (i.e. timed together with the start of the SWOP) is equally effective in 71 
changing exercise performance compared to the application of IPC immediately before a running 72 
event in healthy volunteers. Secondly, we explored whether the effect of (24-h) IPC is related to 73 
changes in local tissue oxygenation (measured with Near-infrared Spectroscopy (NIRS)) of the vastus 74 
lateralis muscle during running exercise and/or production of lactate at the end of exercise. Such 75 
insight may help to better understand the potential mechanisms contributing to the exercise benefits of 76 
(24-h) IPC in humans. 77 
 78 
 79 
METHODS 80 
Adopting a randomized, cross-over study, 12 healthy participants volunteered to participate. Baseline 81 
characteristics are shown in Table 1. Subjects were moderate to well-trained amateur runners (Table 82 
1), who exercised at least two hours a week, including a minimum of one hour running at moderate-to-83 
high intensity. We excluded older participants (>50 years), subjects with cardiovascular disease or any 84 
other chronic disease effecting maximal performance as this may affect the efficacy of IPC 16. Prior to 85 
participation, subjects were informed about the procedures of the study, but not about the rationale of 86 
the study to keep subjects naive about the potential effect of IPC as well as the timing of IPC. All 87 
subjects gave their written informed consent prior to participation. This study was approved by the 88 
local ethics committee of the Radboud University Medical Centre. 89 
 90 
Subjects visited our laboratory at six different occasions (including 3 familiarization sessions to 91 
customise to the 5-km time trial), to perform a 5-km time trial on a treadmill. On the first day, 92 
participants were examined prior to testing by a physician, comprising an assessment of an 93 
electrocardiography under resting conditions. On all testing days, subjects refrained from alcohol, 94 
caffeine, tea, chocolate and (intensive) physical exercise for at least 24 h prior to testing as these 95 
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factors may potentially influence exercise performance. Additionally, subjects were asked to adopt a 96 
similar eating pattern at all days of the measurements. Participants were tested at the same time of day 97 
to control for diurnal variation and its impact on exercise performance 17, while measurements were 98 
performed in a temperature-controlled testing room with the temperature set at 19ºC. Testing days 99 
were separated by at least 4 days, in order to prevent possible carry-over effects of the exercise bout 100 
and/or IPC. 101 
First, participants performed three familiarization sessions on a treadmill. Participants were instructed 102 
to run a 5-km time trial on a motorized treadmill (EN-BO Systems, Bonte BV, the Netherlands) as fast 103 
as possible, while being blinded for time, speed and heart rate, but not running distance. The 104 
familiarization sessions indicated that the coefficient of variation for a self-paced 5-km time trial 105 
varied between 1.6-1.8%. When being familiarized with running the 5-km trial, the experiment started. 106 
In a randomized order, participants received IPC, 24-IPC and SHAM.  Participants were informed that 107 
all interventions, including SHAM, could potentially lead to an improved running performance to keep 108 
them naive. After the application of IPC, participants performed a standardized warm-up, followed by 109 
the 5-km time trial.  110 
 111 
IPC was performed in the supine position using bilateral arterial occlusion 5. Occlusion cuffs were 112 
positioned proximally around the thigh (bilaterally) and inflated to 220 mmHg to block arterial inflow 113 
for 5 minutes, followed by a 5 minute deflation. This procedure was repeated 4 times, with each 114 
ischemic episode separated by 5 minutes rest. For the IPC intervention, this procedure was started 1 115 
hour before the time trial, whilst the procedure was timed exactly 24 hour prior to the time trial for the 116 
24-IPC. 117 
The control intervention was performed under the same conditions as the intervention test, but this 118 
time the cuff was inflated to only 20 mmHg, which did not alter the arterial inflow. No additional 119 
control test (i.e. without cuff inflation) was performed to keep participants naïve regarding any 120 
possible effects of the intervention and, subsequently, to prevent the possibility of a placebo effect. 121 
 122 
   Acute and delayed IPC enhance performances  
 
6 
 
After the IPC/SHAM-intervention, subjects were seated for 5 minutes. Subsequently, subjects 123 
performed a 5-minute warm-up followed by another 5 minutes to stretch their muscles as preferred, 124 
after which the 5-km running time trial was started. The 5-km running trial was performed on a 125 
motorized treadmill. Main outcome parameter was finish time (Fisher Scientific, the Netherlands). The 126 
speed of the treadmill was set at 11 km/h, where after participants were allowed to alter running speed, 127 
but were kept blinded for running speed and running time. Participants were instructed to run 5-km as 128 
fast as possible. The only information available to the participants during each time trial was total 129 
distance covered (m) as to adjust work-output to pace towards the known endpoint. No further 130 
information/feedback and/or encouragements were provided during the 5-km trial.  131 
 132 
NIRS is based on the relative transparency of tissue to light in the near-IR region, and on the oxygen-133 
dependent absorption changes of hemoglobin (Hb) and myoglobin (Mb). Using a continuous-wave 134 
near-IR spectrophotometer (Portamon, Artinis Medical Systems, BV, The Netherlands) that generates 135 
light at 905, 850 and 770 nm, it is possible to differentiate between oxy- and 136 
deoxyhemoglobin/myoglobin (O2Hb/O2Mb and HHb/HMb, respectively). NIRS measurements were 137 
carried out on the belly of the vastus lateralis muscle 12 cm above the fibular head. Quantitative NIRS 138 
measurements of muscle oxygenation (mVO2) from O2Hb were obtained during exercise and 139 
subsequently, tissue saturation index (TSI) was calculated as the percentage of O2Hb/O2Mb of total Hb 140 
and Mb. 141 
 142 
Heart rate was measured continuously by a Polar chest band (Polar® RS 800) and recorded every 143 
500m. Blood pressure was measured at the right arm before, during and after the IPC/SHAM-144 
intervention and after the time trial. Furthermore, a finger capillary blood sample (Accutrend® Lactate, 145 
Roche Diagnostics, Mannheim, Germany) was taken before and after the IPC-/SHAM-intervention, 146 
but also after the 5-km time trial (± 2 min after the exercise bout) to measure blood lactate levels. In 147 
addition, the rate of perceived exertion was registered on a Borg-scale (6-20) during warm up, every 148 
500 m and after the 5-km time trial.  149 
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 150 
Data is presented as mean ± SD, unless stated otherwise. To examine differences in finish time 151 
between the interventions, one-way repeated measures ANOVA was used. To examine whether IPC 152 
and 24-IPC lead to comparable changes in exercise performance (i.e. primary aim of the study), we 153 
used a Pearson correlation coefficient to relate changes in finish time after IPC versus 24-IPC. Using a 154 
2-way ANOVA, we examined whether changes in TSI, heart rate, pace time and BORG during the 155 
time trial (every 500m; ‘time’) differs across the 3 conditions (‘intervention’; SHAM vs IPC vs 24-156 
IPC). Differences across the conditions were analyzed by repeated measures ANOVA. Finally, to 157 
investigate which parameters contributed to the change in exercise performance after IPC or 24-IPC 158 
(i.e. ∆IPC-control, ∆24-IPC–control), a stepwise linear regression analysis was performed. Study 159 
parameters included in this model were presented as the change between IPC versus control or 24-IPC 160 
versus control. Differences were considered to be statistically significant at P<0.05.  161 
 162 
 163 
RESULTS 164 
We found no differences in finish time between IPC, 24-IPC and SHAM (P=0.30, Figure 1A). Also no 165 
significant changes were observed when calculating the change in finish time between IPC versus 166 
SHAM (-16±39s, P=0.14) or 24-IPC versus SHAM (-16±58s, P=0.29).  However, when pooling the 167 
individual changes in finish time after IPC and 24-IPC, the majority of subjects (7 of 12) seem to have 168 
an improved finish time, however this failed to reach statistical significance (P=0.10, Figure 1B, 169 
Figure 2). Interestingly, we found a significant positive relation between the change in finish time after 170 
IPC versus the change after 24-IPC (P=0.016; r=0.677, Figure 2). This relation indicates that the 171 
change in finish time after IPC is strongly related to the change in finish time after 24-h IPC within 172 
individuals.  173 
 174 
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Heart rate gradually increased during the 5-km time trial, with no differences between the 175 
interventions (P=0.63). Pace slightly decreased during the 5-km time trial in the three conditions, with 176 
a significant time*treatment effect for 24-IPC (P=0.016). Post-hoc analysis showed that subjects 177 
started at a higher pace during the 24-IPC time trial and ended with a somewhat lower pace compared 178 
to the other two conditions. All participants reached a similar level of exertion at the end of the 3 time 179 
trials (SHAM: 19 ± 2 BORG, IPC: 19 ± 2 BORG, 24-IPC: 19 ± 2 BORG; P=0.60)). Blood lactate 180 
levels significantly increased after the 5-km time trial, whilst no differences were found among the 3 181 
trials in post-exercise lactate levels (SHAM: 6.4 ± 3.1 mmol/l, IPC: 8.0 ± 2.7 mmol/l, 24-IPC: 7.5 ± 182 
2.2 mmol/l; P=0.30, P=0.24). Finally, TSI, as measured with NIRS on the vastus lateralis muscle, 183 
showed a rapid decrease in saturation upon the start of the 5-km time trial and remained stable 184 
thereafter. This time-dependent change was similar among all three conditions (P=0.14) 185 
 186 
Stepwise linear regression was performed to identify whether exercise characteristics could predict the 187 
change in finish time after IPC or 24-IPC. Post-exercise blood lactate concentration significantly 188 
contributed to the change in running time after IPC or 24-IPC (R2=0.47, β=-0.687, P=0.007). More 189 
specifically, lower post-exercise blood lactate levels after IPC or 24-IPC were significantly related to 190 
an improvement in finish time.  The number of training hours and differences between trials in 191 
maximal heart rate and TSI did not contribute to changes in finish time.  192 
 193 
DISCUSSION 194 
This is the first study to compare the impact of the application of IPC 24-hours before the exercise 195 
bout versus IPC immediately before exercise on performance. Overall, we found no significant effect 196 
of 24-IPC or IPC on exercise performance during a 5-km time trial in moderately-to-well trained 197 
athletes. However, we found a strong and positive relationship between the change in finish time when 198 
the 5-km trial was preceded by IPC versus 24-IPC. This suggests that, at an individual level, 24-IPC 199 
exerts a comparable effect on exercise performance compared to IPC during a 5-km running time trial. 200 
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Practically, athletes competing at a high level could apply IPC 24h before their sporting event.   201 
Finally, improvement in finish time was strongly related to a decrease in post-exercise blood lactate 202 
levels, but not to changes in vastus lateralis muscle oxygenation. Taken together, at an individual 203 
level, the effect sizes of 24-IPC and IPC during a 5-km time trial are strongly related.  204 
 205 
We did not find a significant effect of IPC on exercise performance, which contrast with some 5-11, but 206 
not all studies 11-13. Although not significant, the effect size found in our study is 1.4% reduction in 207 
running time, which corresponds well with other studies that reported a 1- 4% improvement in peak 208 
workload 5, 8, improvement in finish time 6, 7, 10 or prolonged time to exhaustion 9, 11. One potential 209 
explanation for the absence of a significant effect is that our self-selected exercise protocol resulted in 210 
a relatively large variation in running time within participants despite three familiarization sessions 211 
before the actual start. These types of exercise trials are importantly influenced by the athlete’s 212 
experience and motivation 18-21. As a result, the coefficient of variation of the self-paced 5-km time 213 
trial (1.6-1.8%) is somewhat higher than a priori expected. Consequently, more subjects may be 214 
necessary to detect differences when adopting the self-paced 5-km time trial. In support of this 215 
hypothesis, previous work that reported an effect of IPC to improve exercise performance adopted an 216 
exercise protocol where subjects performed exercise at maximal effort level. Indeed, these previous 217 
studies adopted exercise tests that caused substantially larger blood lactate concentration (~12-13 218 
mmol/l) 5, 7 compared to our protocol (~6-8 mmol/l). Taken together, although we found no significant 219 
effect of IPC on exercise performance, the effect size of IPC is comparable to previous studies in this 220 
field. 221 
 222 
The primary aim of our study was to explore whether 24-IPC and IPC would cause comparable 223 
changes in running time. In agreement with our hypothesis, a strong and positive correlation was 224 
found between the change in running time after IPC and 24-IPC. Similarly, those who did not show 225 
improvement in running time after IPC, also showed no change after 24-IPC. Although our study is 226 
the first in the literature to demonstrate that IPC and 24-IPC have comparable effects on exercise 227 
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performance, these findings are largely in agreement with previous work on IPC and protection of 228 
cardiac damage by SWOP. Previous work on the cardioprotective effects of IPC and 24-IPC found 229 
comparable protection against prolonged ischaemia 22-24, although some data is conflicting 25. Taken 230 
together, our data extends previous work in the area of cardiology, in that the effect of 24-IPC on 231 
exercise performance is comparable to that observed after IPC. 232 
 233 
In an attempt to better understand the underlying mechanisms, we explored tissue saturation of the 234 
vastus lateralis muscle during the time trial. Previous work in animals linked IPC to improved muscle 235 
oxygenation during exercise 26. Studies that have measured TSI, report a 20% decrease in TSI after 236 
IPC relative to control 10, 27. In our study, we found that IPC and 24-IPC exerted a similar impact on 237 
TSI during exercise than SHAM 27. This observation suggests that IPC and 24-IPC did not alter 238 
muscle oxygen delivery during exercise 28. This is supported by our regression analysis. 239 
 240 
An alternative explanation for the underlying mechanisms relates to blood lactate levels during 241 
exercise. Previous work demonstrated that changes in blood lactate concentration and mitochondrial 242 
capacity account for 68% of the variation in cycling time trial performance 29. Furthermore, lower 243 
blood lactate concentrations at a given workload improves endurance exercise in various populations, 244 
including in highly trained 24. These observations are somewhat in line with earlier observations from 245 
Bailey et al., who demonstrated that IPC lowers blood lactate levels during running exercise at 246 
submaximal intensity 6. Interestingly, running speed associated with lower blood lactate levels after 247 
IPC matched with the running speed of the 5-km time trial 6. Therefore, our findings provide some 248 
further support that IPC may enhance exercise performance through changes in the lactate pathways.  249 
Although we included three familiarizations sessions prior to testing, the relatively high day-to-day 250 
variability of 1.6-1.8% in athlete’s performance could have influenced our results, especially since the 251 
effect size of 1.4 % was somewhat smaller than initially anticipated. Interestingly, when all data from 252 
IPC and 24-IPC are pooled (n=24), we found a trend for a decline in the time trial (P=0.10).   253 
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Conclusions 254 
• A strong relation is present between acute IPC and 24-IPC, which  suggests that the effects of  255 
IPC and 24-IPC are closely related on an individual level. 256 
• Lower post-exercise blood lactate levels after IPC or 24-IPC is significantly related to an 257 
improvement in finish time.   258 
• Differences in TSI, did not contribute to changes in finish time. 259 
Practical Implications 260 
• IPC may improve exercise performance, although further research is necessary to indicate 261 
whether  exercise intensity, and hence blood lactate levels are important determinants for an 262 
IPC effect. 263 
• On an individual level, 24-IPC is as effective as acute IPC, which implicates that both can be 264 
used preceding a contest.  265 
• 24-IPC m represents a more feasible and practical approach compared to the application of 266 
IPC immediately before the exercise event. 267 
 268 
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FIGURE LEGENDS 350 
FIGURE 1.  Individual presentation (n=12) of the finish time during the SHAM, IPC and 24-IPC 351 
intervention (A, in seconds) and the change in finish time compared to SHAM after 352 
application of IPC or 24-IPC (B, in seconds). A negative value in B relates to a better 353 
finish time. Each dot represents a single participant. The horizontal line represents the 354 
average, with the error bars representing the SE. 355 
 356 
FIGURE 2: Correlation between the individual changes in finish time compared to SHAM after 357 
application of IPC (X-axis, in seconds) and the change in finish time between SHAM 358 
and 24-IPC (Y-axis, in seconds) in our participants (n=12). A negative value on both 359 
axes relates to a better finish time after IPC or 24-IPC. The dotted line represents the 360 
regression line from the Pearson’s correlation coefficient. 361 
